Associate professor | Wuhan University | China
Guohua Yang is an Associate Professor at Wuhan University, specializing in medical genetics and genetic diseases. His research focuses on gene mutations, novel diagnostic methods, and drug discovery for hepatocellular carcinoma. As a dedicated scholar, he holds various leadership roles in genetic and medical associations, contributing significantly to the field.
Profile👤
ORCID
Scopus
Strengths for the Awards
- Strong Research Focus
- Expertise in gene mutation and genetic diseases, gene diagnosis, and hepatocellular carcinoma.
- Contribution to cutting-edge molecular mechanisms and drug discovery research.
- Notable Publications & Impact
- Published in reputable journals such as BMC Medical Genomics, Naunyn Schmiedebergs Archives of Pharmacology, Carbohydrate Polymers, Frontiers in Genetics, and Oxidative Medicine and Cellular Longevity.
- Publications demonstrate interdisciplinary research, integrating genetics, pharmacology, and computational biology.
- Editorial & Professional Leadership
- Guest editor and editorial board member for Frontiers in Genetics and Spandidos Journal.
- Holds leadership roles in multiple genetics and medical associations, indicating high recognition in the field.
- Innovative Research Applications
- Contributions to cancer research, including targeted therapies and machine learning-based biomarker identification.
- Research has potential clinical applications, making a significant societal impact.
- Guohua Yang is a strong candidate for the Best Researcher Award due to his pioneering contributions to medical genetics, leadership in scientific organizations, and high-quality publications. While he possesses impressive academic credentials, addressing funding, patent contributions, and industry collaborations could further strengthen his profile. Nonetheless, his work in hepatocellular carcinoma and gene mutation research makes him a valuable contender.
🎓 Education
Guohua Yang has received extensive training in medical genetics and related disciplines, equipping him with the expertise to explore genetic disorders and innovative treatment approaches. His educational background has laid a strong foundation for his research in genetic mutations, reproductive health, and cancer biology.
🏢 Experience
As an Associate Professor at Wuhan University, Dr. Yang has led numerous studies on gene mutations and their roles in genetic diseases and cancer progression. He has served as a guest editor for Frontiers in Genetics and is an editorial board member for Spandidos Journal and Brain Research. His leadership extends to serving on various committees, such as the Gene Health Branch of Hubei Genetic Society and the Medical Genetics Branch of Hubei Medical Association.
🔬 Research Interests On Genetics
Dr. Yang’s research revolves around:
- Genetic mutations and their impact on inherited diseases 🧬
- Development of advanced gene diagnostic methods 🏥
- Molecular mechanisms and targeted drug discovery for hepatocellular carcinoma 💊
🏆 Awards
Dr. Yang has been recognized for his outstanding contributions to medical genetics and has been nominated for the Best Researcher Award for his pioneering work in genetic disease research and precision medicine.
📚 Publications
Dr. Yang has contributed to several high-impact journals, with research spanning genetic disorders, cancer therapy, and bioinformatics:
- “Truncated FRMD7 proteins in congenital Nystagmus: novel frameshift mutations and proteasomal pathway implications”
- Authors: Y. Su, J. Zhang, J. Gao, Y. Li, G. Yang
- Publication Year: 2024
- Citations: 0
- “Lessons from two patients with Prader–Willi syndrome attributed to heterodisomy and isodisomy”
- Authors: H. Zhou, J. Zhou, S. Xu, G. Yang, K. Wu
- Publication Year: 2024
- Citations: 0
- “Autophagy inhibition mediated by trillin promotes apoptosis in hepatocellular carcinoma cells via activation of mTOR/STAT3 signaling”
- Authors: G. Zhan, T. Wei, H. Xie, S. Li, G. Yang
- Publication Year: 2024
- Citations: 3
- Clinic Examination and Gene Diagnosis for a Birt–Hogg–Dubé Syndrome Family With a Novel flcn Frameshift Mutation Causing Nonsense‐Mediated mRNA Degradation
- Year: 2025
- Authors: Yang Xu, Jie Gao, Yang An, Chenxi Zou, Guoqing Ding, Guohua Yang, Finlay Macrae
- A novel TSC1 frameshift mutation c.1550_1551del causes tuberous sclerosis complex by aberrant splicing and nonsense‐mediated mRNA degradation (NMD) simultaneously in a Chinese family
- Year: 2020
- Authors: Cong Qiu, Chengyan Li, Xiaoyun Tong, Luoyang Dai, Wenda Liu, Yulie Xie, Qimei Zhang, Guohua Yang, Tao Li
- Identification and Interaction Analysis of Significant Genes and MicroRNAs in Pterygium
- Year: 2019
- Authors: Siying He, Hui Sun, Yifang Huang, Shiqi Dong, Chen Qiao, Shuai Zhang, Chen Wang, Fang Zheng, Ming Yan, Guohua Yang
🔚 Conclusion
Dr. Guohua Yang has made significant strides in the field of medical genetics, particularly in gene mutation studies and cancer research. His editorial contributions, leadership roles, and groundbreaking research continue to shape the future of genetic diagnostics and targeted therapies.
